Rara logo

Rara

Founded by jewelers and gemologists, Rara combines fine jewelry with expert guidance to help you stay inspired and enjoy

25 employees · est. 2016 · New York, United States

VS
Syros Pharmaceuticals logo

Syros Pharmaceuticals

By redefining the power of small molecules to control gene expression, we aim to provide a profound benefit for patients

88 employees · est. 2012 · Cambridge, United States

Syros Pharmaceuticals is the older company (2016 vs 2012); Syros Pharmaceuticals is the larger of the two.

Side-by-Side Comparison

Rara Syros Pharmaceuticals
Founded
2016 2012 older
Headquarters
New York, United States Cambridge, United States
Employees
25 88 larger
Industry
Consumer Goods, Fashion, Manufacturing Biotechnology, Life Sciences, Pharmaceutical
Funding Stage
Pre Seed IPO
Total Funding
Not tracked yet $494.90M
Funding Rounds
Not tracked yet 11
Services
Not tracked yet Not tracked yet
Target Customers
Not tracked yet Not tracked yet
Taxonomy
Not tracked yet Gene Expression Control, Hematologic Malignancies, Small Molecule Therapeutics, RARα Agonist, Myelodysplastic Syndrome, RARA Gene Overexpression, Oncology, Gene Regulatory Circuits, Drug Discovery, Bioinformatics, Assay Technologies, Genomic Data Integration, Biologic Insights
Website
rara.jewelry syros.com
Rara logo

About Rara

Rara, founded in 2016, is a startup specializing in the fusion of fine jewelry and expert guidance to create personalized, everyday pieces. Their slogan, “Founded by jewelers and gemologists, Rara combines fine jewelry with expert guidance to help you stay inspired and enjoy,” embodies their mission...

Syros Pharmaceuticals logo

About Syros Pharmaceuticals

Syros Pharmaceuticals, founded in 2012, is a trailblazer in the Biotechnology and Pharmaceutical industries, known for its mission: "By redefining the power of small molecules to control gene expression, we aim to provide a profound benefit for patients". Headquartered in the United States, Syros is...

We will tell you when either one moves

BounceWatch watches Rara and Syros Pharmaceuticals for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Rara and Syros Pharmaceuticals — by email.

Frequently Asked Questions

Rara — Founded by jewelers and gemologists, Rara combines fine jewelry with expert guidance to help you stay inspired and enjoy. Syros Pharmaceuticals — By redefining the power of small molecules to control gene expression, we aim to provide a profound benefit for patients. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Rara has raised undisclosed funding while Syros Pharmaceuticals has raised $494.90M.
Rara and Syros Pharmaceuticals operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Rara with someone else

Start typing a company name or domain.

Related Comparisons

Compiled from the BounceWatch company index. We last looked at Syros Pharmaceuticals on 27 May 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy